Statistics

Total Visits

Views
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.8

Select a period of time:

Number of views in the range

Views
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.7

Views

Views
November 20231
December 20230
January 20242
February 20240
March 20241
April 20240
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Boardman2
Ashburn1
Chicago1